R
0.976
-0.03 (-3.37%)
| Previous Close | 1.01 |
| Open | 1.01 |
| Volume | 74,382 |
| Avg. Volume (3M) | 256,303 |
| Market Cap | 34,490,960 |
| Price / Earnings (Forward) | 59.17 |
| Price / Sales | 0.330 |
| Price / Book | 1.10 |
| 52 Weeks Range | |
| Earnings Date | 6 Aug 2025 - 11 Aug 2025 |
| Profit Margin | -0.27% |
| Operating Margin (TTM) | -7.19% |
| Diluted EPS (TTM) | -0.010 |
| Quarterly Revenue Growth (YOY) | -16.60% |
| Total Debt/Equity (MRQ) | 40.82% |
| Current Ratio (MRQ) | 2.95 |
| Operating Cash Flow (TTM) | 3.10 M |
| Levered Free Cash Flow (TTM) | 1.22 M |
| Return on Assets (TTM) | 0.68% |
| Return on Equity (TTM) | -1.01% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - Specialty & Generic (US) | Bearish | Mixed |
| Drug Manufacturers - Specialty & Generic (Global) | Bearish | Mixed | |
| Stock | Rockwell Medical, Inc. | Bearish | Bearish |
AIStockmoo Score
0.5
| Analyst Consensus | -0.5 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -0.5 |
| Average | 0.50 |
|
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Investment Style | Small Value |
| % Held by Insiders | 12.70% |
| % Held by Institutions | 20.56% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Globeflex Capital L P | 31 Mar 2025 | 743,256 |
| 52 Weeks Range | ||
| Median | 3.00 (207.38%) | |
| Total | 1 Buy | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| HC Wainwright & Co. | 24 Mar 2025 | 3.00 (207.38%) | Buy | 1.26 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 12 May 2025 | Announcement | Rockwell Medical Announces First Quarter 2025 Results |
| 14 Apr 2025 | Announcement | Rockwell Medical to Release First Quarter 2025 Results on Monday, May 12, 2025 |
| 20 Mar 2025 | Announcement | Rockwell Medical Announces Fourth Quarter and Full-Year 2024 Financial and Operational Results |
| 11 Mar 2025 | Announcement | Rockwell Medical to Exhibit at DialysisTechConneXion42 in Booth# 112 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |